|
1
|
Labianca R and Merelli B: Screening and
diagnosis for colorectal cancer: present and future. Tumori.
96:889–901. 2010.PubMed/NCBI
|
|
2
|
Moser AR, Luongo C, Gould KA, McNeley MK,
Shoemaker AR and Dove WF: ApcMin: a mouse model for intestinal and
mammary tumorigenesis. Eur J Cancer. 31A:1061–1064. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baltgalvis KA, Berger FG, Pena MM, Davis
JM, Muga SJ and Carson JA: Interleukin-6 and cachexia in
ApcMin/+ mice. Am J Physiol Regul Integr Comp Physiol.
294:R393–R401. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McClellan JL, Davis JM, Steiner JL, et al:
Intestinal inflammatory cytokine response in relation to
tumorigenesis in the Apc(Min/+) mouse. Cytokine. 57:113–119.
2012.PubMed/NCBI
|
|
5
|
Argiles JM, Busquets S, Garcia-Martinez C
and Lopez-Soriano FJ: Mediators involved in the cancer
anorexia-cachexia syndrome: past, present, and future. Nutrition.
21:977–985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schiaffino S and Mammucari C: Regulation
of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights
from genetic models. Skelet Muscle. 1:42011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Egan D, Kim J, Shaw RJ and Guan KL: The
autophagy initiating kinase ULK1 is regulated via opposing
phosphorylation by AMPK and mTOR. Autophagy. 7:643–644. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hahn-Windgassen A, Nogueira V, Chen CC,
Skeen JE, Sonenberg N and Hay N: Akt activates the mammalian target
of rapamycin by regulating cellular ATP level and AMPK activity. J
Biol Chem. 280:32081–32089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Burch GE, Phillips JH and Ansari A: The
cachetic heart. A clinico-pathologic, electrocardiographic and
roentgenographic entity. Dis Chest. 54:403–409. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
White JP, Baltgalvis KA, Puppa MJ, Sato S,
Baynes JW and Carson JA: Muscle oxidative capacity during
IL-6-dependent cancer cachexia. Am J Physiol Regul Integr Comp
Physiol. 300:R201–R211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
White JP, Baynes JW, Welle SL, et al: The
regulation of skeletal muscle protein turnover during the
progression of cancer cachexia in the Apc(Min/+) mouse. PLoS One.
6:e246502011.
|
|
12
|
Lima M, Sato S, Enos RT, Baynes JW and
Carson JA: Development of an UPLC-mass spectrometry method for
measurement of myofibrillar protein synthesis: analysis of murine
muscles during cancer cachexia. J Appl Physiol. 114:824–828. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cosper PF and Leinwand LA: Cancer causes
cardiac atrophy and autophagy in a sexually dimorphic manner.
Cancer Res. 71:1710–1720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Costelli P, Tullio RD, Baccino FM and
Melloni E: Activation of Ca(2+)-dependent proteolysis in skeletal
muscle and heart in cancer cachexia. Br J Cancer. 84:946–950.
2001.
|
|
15
|
Fujita J, Tsujinaka T, Yano M, et al:
Anti-interleukin-6 receptor antibody prevents muscle atrophy in
colon-26 adenocarcinoma-bearing mice with modulation of lysosomal
and ATP-ubiquitin-dependent proteolytic pathways. Int J Cancer.
68:637–643. 1996. View Article : Google Scholar
|
|
16
|
Strassmann G, Masui Y, Chizzonite R and
Fong M: Mechanisms of experimental cancer cachexia. Local
involvement of IL-1 in colon-26 tumor. J Immunol. 150:2341–2345.
1993.PubMed/NCBI
|
|
17
|
Wysong A, Couch M, Shadfar S, et al:
NF-kappaB inhibition protects against tumor-induced cardiac atrophy
in vivo. Am J Pathol. 178:1059–1068. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carson JA and Baltgalvis KA: Interleukin 6
as a key regulator of muscle mass during cachexia. Exerc Sport Sci
Rev. 38:168–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mandel ID, Barr CE and Turgeon L:
Longitudinal study of parotid saliva in HIV-1 infection. J Oral
Pathol Med. 21:209–213. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Wang HY, Bassel-Duby R, et al:
Role of interleukin-6 in cardiac inflammation and dysfunction after
burn complicated by sepsis. Am J Physiol Heart Circ Physiol.
292:H2408–H2416. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Hall G, Steensberg A, Fischer C, et
al: Interleukin-6 markedly decreases skeletal muscle protein
turnover and increases nonmuscle amino acid utilization in healthy
individuals. J Clin Endocrinol Metab. 93:2851–2858. 2008.PubMed/NCBI
|
|
22
|
Kelly M, Keller C, Avilucea PR, et al:
AMPK activity is diminished in tissues of IL-6 knockout mice: the
effect of exercise. Biochem Biophys Res Commun. 320:449–454. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chan AY and Dyck JR: Activation of
AMP-activated protein kinase (AMPK) inhibits protein synthesis: a
potential strategy to prevent the development of cardiac
hypertrophy. Can J Physiol Pharmacol. 83:24–28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Latronico MV, Costinean S, Lavitrano ML,
Peschle C and Condorelli G: Regulation of cell size and contractile
function by AKT in cardiomyocytes. Ann NY Acad Sci. 1015:250–260.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang E, Zha J, Jockel J, Boise LH,
Thompson CB and Korsmeyer SJ: Bad, a heterodimeric partner for
Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell.
80:285–291. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zha J, Harada H, Yang E, Jockel J and
Korsmeyer SJ: Serine phosphorylation of death agonist BAD in
response to survival factor results in binding to 14-3-3 not
BCL-X(L). Cell. 87:619–628. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kandarian SC and Jackman RW: Intracellular
signaling during skeletal muscle atrophy. Muscle Nerve. 33:155–165.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Martin DE and Hall MN: The expanding TOR
signaling network. Curr Opin Cell Biol. 17:158–166. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang X and Proud CG: The mTOR pathway in
the control of protein synthesis. Physiology. 21:362–369. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Levine B and Yuan J: Autophagy in cell
death: an innocent convict? J Clin Invest. 115:2679–2688. 2005.
View Article : Google Scholar : PubMed/NCBI
|
